<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="discussion"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38124746</article-id><article-id pub-id-type="pmc">PMC10731019</article-id><article-id pub-id-type="doi">10.3389/fimmu.2023.1242306</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Opinion</subject></subj-group></subj-group></article-categories><title-group><article-title>&#x003b3;&#x003b4; T cells as immunotherapy for malaria: balancing challenges and opportunities</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vig&#x000e1;rio</surname><given-names>Ana M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2262320"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Pamplona</surname><given-names>Ana</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2278657"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Projecto Medicina, Faculdade de Ci&#x000ea;ncias da Vida, Universidade da Madeira</institution>, <addr-line>Funchal</addr-line>, <country>Portugal</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Instituto de Medicina Molecular Jo&#x000e3;o Lobo Antunes, Faculdade de Medicina de Lisboa</institution>, <addr-line>Lisboa</addr-line>, <country>Portugal</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Herbert Leonel de Matos Guedes, Federal University of Rio de Janeiro, Brazil</p></fn><fn fn-type="edited-by"><p>Reviewed by: Claudio Romero Farias Marinho, University of S&#x000e3;o Paulo, Brazil</p></fn><corresp id="fn001">*Correspondence: Ana Pamplona, <email xlink:href="mailto:anapamplona@medicina.ulisboa.pt">anapamplona@medicina.ulisboa.pt</email>
</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>14</volume><elocation-id>1242306</elocation-id><history><date date-type="received"><day>06</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2023 Vig&#x000e1;rio and Pamplona</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Vig&#x000e1;rio and Pamplona</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><kwd-group><kwd>gamma-delta (&#x003b3;&#x003b4;) T lymphocytes</kwd><kwd>malaria</kwd><kwd><italic>Plasmodium</italic></kwd><kwd>human malaria</kwd><kwd>vaccine</kwd><kwd>immune response</kwd><kwd>Immunotherapy</kwd></kwd-group><funding-group><funding-statement>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AP holds a research position funded by Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e a Tecnologia (Decree&#x02010;law no. 57/2016 of July 19, as amended by the Law no. 57/2017).</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="71"/><page-count count="6"/><word-count count="3074"/></counts><custom-meta-group><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Parasite Immunology</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Malaria remains a relevant global health problem. In 2021, the WHO estimated 247 million cases worldwide, which led to more than 600,000 deaths, mainly due to severe malaria caused by <italic>Plasmodium falciparum</italic> (<xref rid="B1" ref-type="bibr">1</xref>). The different infection outcomes, such as sterile immunity, clinical immunity, and detrimental immune responses observed in severe malaria, are due to the interplay between the parasite and the host. In natural infections, malaria is transmitted after <italic>Plasmodium</italic> sporozoites (Spz) are delivered into the skin during a blood meal of an infected anopheline mosquito and then migrate to the liver. Once inside a hepatocyte, Spz matures and replicates, forming a schizont containing thousands of merozoites, constituting the asymptomatic phase of infection (<xref rid="B2" ref-type="bibr">2</xref>). Then, merozoites are released, enter the bloodstream, and infect red blood cells (RBC), initiating the blood-stage infection, which constitutes the symptomatic phase (<xref rid="B3" ref-type="bibr">3</xref>).</p><p>Therefore, the life cycle of <italic>Plasmodium</italic> involves multiple stages and tissues (skin, liver, and blood), making it difficult to understand the immune responses to the parasite within the vertebrate host. However, creating several opportunities for intervention.</p><p>Gamma-delta (&#x003b3;&#x003b4;) T cells are an immune cell population with increased interest in malaria infection. The singular features of &#x003b3;&#x003b4; T cells, such as their tissue tropism, pro-inflammatory phenotype, cytotoxic potential, MHC-independent antigen recognition, and properties of natural killer-like cells, make them very interesting targets for therapeutic interventions and vaccine development (<italic>reviewed in</italic> (<xref rid="B4" ref-type="bibr">4</xref>)), especially since they have been considered a feasible and promising approach for other clinical situations as cancer immunotherapy (<italic>reviewed in</italic> (<xref rid="B5" ref-type="bibr">5</xref>)). Nevertheless, the identification of the antigens recognized by &#x003b3;&#x003b4; T cells and the subsets involved in protection against malaria, which has been quite challenging, is crucial for understanding the potential clinical application of these cells.</p></sec><sec id="s2"><title>&#x003b3;&#x003b4; T cells &#x02014; of mice and humans</title><p>Mouse models have been instrumental in our understanding of malaria parasite biology and the immunopathogenesis of malaria infection and have provided proof of concept for several candidate vaccines and drug discovery. Although mouse models have provided mechanistic insight into &#x003b3;&#x003b4; T cell biology, human and rodent <italic>Plasmodium</italic> species genomes and mouse and human biology are very different, including on &#x003b3;&#x003b4; T cells tissue distribution, TCR diversity and effector functions by producing distinct cytokines when stimulated (<italic>reviewed in</italic> (<xref rid="B6" ref-type="bibr">6</xref>)). These aspects may difficult the direct translation of knowledge gained from mouse models, such as host&#x02013;parasite interactions and immune responses, into effective treatment in humans. By other hand, while controlled human malaria infection (CHMI) and human clinical trials provide direct evidence of immune responses to malaria, these studies are usually limited to peripheral blood correlates of protection (<italic>reviewed in</italic> (<xref rid="B7" ref-type="bibr">7</xref>)).</p></sec><sec id="s3"><title>&#x003b3;&#x003b4; T cells and <italic>Plasmodium</italic> pre-erythrocytic stage &#x02013; skin an overlooked immune barrier</title><p>Although the <italic>Plasmodium</italic> pre-erythrocytic stage has been mainly a designation for the liver stage of infection, we cannot overlook that <italic>Plasmodium</italic> infection begins with the inoculation of Spz in the skin. Several studies performed in mice observed that after inoculation, more than 50% of Spz remain in the skin, particularly in the dermis, and the remaining migrate to the draining lymph nodes (dLN) through lymph vessels or to the liver through blood circulation (<xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B10" ref-type="bibr">10</xref>). The skin exit of Spz is therefore a bottleneck for successful infection. Indeed, during the skin step, the parasite is more vulnerable to host-immune responses because of the extracellular nature of this stage (<xref rid="B11" ref-type="bibr">11</xref>). During this journey, Spz encounters various skin-resident cells, including &#x003b3;&#x003b4; T cells. Studies in mice and humans have shown that Spz remaining in the dermis are taken up by resident DCs, which can prime CD4+ (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>) and CD8+ (<xref rid="B14" ref-type="bibr">14</xref>) T-cell responses after migrating to the skin-dLN. These studies showed that skin immune responses impact the induction of T-cell-dependent liver immunity. Interestingly, in a dengue virus infection model, skin mast cell-driven inflammation induced local recruitment and proliferation of &#x003b3;&#x003b4; T cells (<xref rid="B15" ref-type="bibr">15</xref>). In other infections, such as Bacillus Calmette-Guerin (BCG), dermal IL-17-producing &#x003b3;&#x003b4; T cells increase CD4+ T cell proliferation by inducing neutrophil recruitment, which contributes to antigen delivery to the dLN (<xref rid="B16" ref-type="bibr">16</xref>). In addition, in a more recent study using a model of chronic <italic>Trypanosoma brucei</italic> infection, the authors showed that IL-17- producing V&#x003b3;6+ cells play a critical role in controlling skin inflammation, likely limiting, either directly or indirectly, dermal IFN&#x003b3;-mediated CD8+ T cell responses (<xref rid="B17" ref-type="bibr">17</xref>). Overall, these studies provide new insights into the role of skin &#x003b3;&#x003b4; T cell as important players in immunity during infection. Mice lacking canonical dendritic epidermal T cells (DETCs), such as Trgv5-/-Trdv4-/- mice or FVB.Tac mice deficient for V&#x003b3;5V&#x003b4;1 due to a mutation in Skint1 (<xref rid="B18" ref-type="bibr">18</xref>), a butyrophilin-like protein essential for the selective development of the TCR-V&#x003b3;5V&#x003b4;1-expressing repertoire of murine DETCs (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>), or blocking intradermal Skint1 (<xref rid="B19" ref-type="bibr">19</xref>), and double V&#x003b3;4/6 T cell knockout mice (on an FVB/N genetic background) (<xref rid="B17" ref-type="bibr">17</xref>) could be used as strategies to evaluate the relevance of DETCs or dermal &#x003b3;&#x003b4; T cell populations after Spz inoculation in the skin. Notably, skin &#x003b3;&#x003b4; T cell can be of particular importance if we want to improve the vaccination strategy for malaria or other infectious diseases using skin-deliverable vaccines (<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B24" ref-type="bibr">24</xref>) (<italic>reviewed in</italic> (<xref rid="B25" ref-type="bibr">25</xref>)). Thus, a better understanding of the crosstalk between skin &#x003b3;&#x003b4; T cell subsets and other local cells and the immunological pathways that are triggered after Spz infection is urgently required. The same applies to parasite antigens that can be recognized by skin &#x003b3;&#x003b4; T cells.</p></sec><sec id="s4"><title>&#x003b3;&#x003b4; T cells and <italic>Plasmodium</italic> pre-erythrocytic stage</title><p>The human liver is enriched with V&#x003b4;2- &#x003b3;&#x003b4; T subsets, mainly by V&#x003b4;1+ but also by V&#x003b4;3+, combined with diverse V&#x003b3; chains (<xref rid="B26" ref-type="bibr">26</xref>). Human V&#x003b4;3+ T cells are activated by CD1d-mediated recognition of glycolipids (<xref rid="B27" ref-type="bibr">27</xref>) and release IL-17A after activation (<xref rid="B27" ref-type="bibr">27</xref>), and V&#x003b4;1 TCRs can recognize MICA and MICB ligands expressed by stressed cells (<xref rid="B28" ref-type="bibr">28</xref>) and several CD1d- and CD1c-presented glycolipids (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B29" ref-type="bibr">29</xref>). The intrahepatic &#x003b3;&#x003b4; T subsets undergo clonal expansion and differentiation in the context of liver virus infection (<xref rid="B26" ref-type="bibr">26</xref>). A liver-resident CD27loCD45RAlo subset of V&#x003b4;1+ T cells expressing CXCR3 and CXCR6 and producing IFN-&#x003b3; and TNF-&#x003b1; were identified in humans (<xref rid="B26" ref-type="bibr">26</xref>). Interestingly, in a mouse model of HBV infection, liver resident &#x003b3;&#x003b4; T cells also expressing CXCR3+CXCR6+ produced high levels of IFN-&#x003b3;, providing protection against acute HBV infection (<xref rid="B30" ref-type="bibr">30</xref>). These studies suggest a therapeutic potential of &#x003b3;&#x003b4; T cells on liver infections (<xref rid="B26" ref-type="bibr">26</xref>).</p><p>The crosstalk between the liver and the symptomatic blood stages of <italic>Plasmodium</italic> infection has been challenging to study and is thus still poorly understood. A study using a mouse model revealed that IFN&#x003b3;-producing &#x003b3;&#x003b4; T cells play a pathogenic role that is strictly dependent on the liver stage of infection, and affecting disease severity (<xref rid="B31" ref-type="bibr">31</xref>). This study represents an important step toward understanding the role of &#x003b3;&#x003b4; T cells and the impact of the liver stage on the pathogenesis of <italic>Plasmodium</italic> infection (<xref rid="B31" ref-type="bibr">31</xref>), which was corroborated by a more recent study (<xref rid="B32" ref-type="bibr">32</xref>). In this last study, mice were first infected with non-productive Spz that do not transit between the liver and blood stages, followed by low or high doses of infected RBCs two days later (<xref rid="B32" ref-type="bibr">32</xref>). In this experimental approach the &#x003b3;&#x003b4; T cells came into two flavors. On the one hand, protective IL-17-producing &#x003b3;&#x003b4; T cells expand following low doses of infected RBCs, while IFN&#x003b3;-producing &#x003b3;&#x003b4; T cells are induced after high doses of infected RBCs, contributing to disease severity (<xref rid="B32" ref-type="bibr">32</xref>). However, it remains to be determined whether a human IL-17-producing &#x003b3;&#x003b4; T cell counterpart exists. This study highlights the dichotomous nature of &#x003b3;&#x003b4; T cells in malaria infection. In this context, clarifying the potential dual role of &#x003b3;&#x003b4; T cells in protection <italic>versus</italic> pathogenesis may provide new avenues for treatment against malaria.</p><p>Increased evidence using whole Spz immunizations in humans and mice shows an important role for &#x003b3;&#x003b4; T cells in protection from subsequent infection (<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B36" ref-type="bibr">36</xref>). In a mouse model, induction of &#x003b3;&#x003b4; T cells after Spz immunization induced protective immunity against parasites in the absence of &#x003b1;&#x003b2; T cells (<xref rid="B35" ref-type="bibr">35</xref>). In another study, a subset of &#x003b3;&#x003b4; T cells, along with CD8&#x003b1;<sup>+</sup> DC, was required for the induction of protective CD8+ T cell responses (<xref rid="B34" ref-type="bibr">34</xref>). Overall, the mechanism involving &#x003b3;&#x003b4; T cells-protective role is still unclear, namely whether they act as effector cells or as accessory cells inducing protective CD8+ T cell responses. Importantly, there is still limited knowledge of liver-resident &#x003b3;&#x003b4; T cells and which subset induces effector CD8+ T cell responses. Understanding the mechanisms of protection by &#x003b3;&#x003b4; T cells is crucial for developing vaccine strategies against the pre-erythrocytic stage.</p></sec><sec id="s5"><title>&#x003b3;&#x003b4; T cells and <italic>Plasmodium</italic> erythrocytic stage</title><p>In humans, the accessibility and symptomatic features of the erythrocytic stage make it less challenging to study and implement therapeutic interventions. During this stage, &#x003b3;&#x003b4; T cells from the peripheral blood and secondary lymphoid organs, particularly the spleen, may encounter parasite antigens or interact with stress-induced molecules expressed by different types of cells in response to infection. Moreover, infected RBCs (iRBCs) are sequestered in the microvasculature of many organs, both in mice and humans (<xref rid="B37" ref-type="bibr">37</xref>&#x02013;<xref rid="B39" ref-type="bibr">39</xref>), favoring the interaction of peripheral and tissue-resident &#x003b3;&#x003b4; T cells with parasite antigens (<xref rid="B40" ref-type="bibr">40</xref>).</p><p>While V&#x003b4;1 cells are the main &#x003b3;&#x003b4; T cell subset observed in tissues, V&#x003b3;9+V&#x003b4;2+ are the predominant subset in the peripheral blood of healthy adults (<xref rid="B41" ref-type="bibr">41</xref>&#x02013;<xref rid="B44" ref-type="bibr">44</xref>) and may significantly expand during infections (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Nevertheless, it remains unclear how V&#x003b3;9+V&#x003b4;2+ T cells are activated and how they contribute to the control of the erythrocytic stage of the parasite. Previous work suggested that soluble molecules, such as phosphoantigens released by mature forms of <italic>P. falciparum</italic>, when cells egress from the iRBCs can activate <italic>in vitro</italic> the V&#x003b3;9+V&#x003b4;2+ T in a contact-independent manner (<xref rid="B40" ref-type="bibr">40</xref>). The relevance of this contact-independent activation in controlling circulating iRBC levels <italic>in vivo</italic> is difficult to assess because these molecules are quite diluted in the bloodstream. However, this does not exclude the possibility that this activation mechanism may occur in specific sites, such as the red pulp of the spleen, where iRBCs are retained, or in microvessels where iRBCs can sequester and reduce blood flow (<xref rid="B40" ref-type="bibr">40</xref>). Recently, however, a study showed that V&#x003b3;9+V&#x003b4;2+ T cells recognize, through their &#x003b3;&#x003b4; TCR, butyrophilin 3A1 (BTN3A1) expressed by all forms of the parasite, except merozoites, in iRBCs (<xref rid="B47" ref-type="bibr">47</xref>). This interaction between TCR and BTN3A1 induced the release of both granulysin and granzyme and directly killed iRBCs (<xref rid="B47" ref-type="bibr">47</xref>). V&#x003b3;9+&#x003b4;2+ T cells also phagocytized and degraded antibody-coated iRBCs in a CD16-dependent manner (<xref rid="B47" ref-type="bibr">47</xref>). In fact, peripheral V&#x003b3;9+V&#x003b4;2+ T cells from <italic>P. falciparum</italic>&#x02013;infected patients showed an <italic>in vivo</italic> increased surface expression of antigen-presenting cell (APC)-associated markers, upregulated these markers upon stimulation <italic>in vitro</italic> with iRBC, and activated naive CD4+ and CD8+ T cells demonstrating APC capacity (<xref rid="B48" ref-type="bibr">48</xref>). A recent report showed that in macaques, a single immunization with a V&#x003b3;9+V&#x003b4;2+ T cell specific ligand induced a durable memory-like response and amplified IFN-&#x003b3; responses by other T cell subsets, i.e., CD4+ and CD8+ T cells, reducing <italic>Mycobacterium tuberculosis</italic> pathology and infection (<xref rid="B49" ref-type="bibr">49</xref>), an encouraging finding for their potential application in <italic>Plasmodium</italic> infection.</p><p>Thus, the role of &#x003b3;&#x003b4; T cells in the induction and modulation of the adaptive immune response to malaria must be fully understood, as these findings pave the way for their use in therapeutic interventions and vaccine design improvement. In addition to the above features, &#x003b3;&#x003b4; T cells, when activated, produce different cytokines depending on the subset, ligands, stage of infection, and previous exposure to the antigen. These factors may dictate their functional role, protective or pathogenic, during the erythrocytic stage, making therapeutic intervention more challenging to develop and implement. Notably, cytokines produced by &#x003b3;&#x003b4; T cells in response to infection may modulate immune memory by influencing the antibody response, which could be very interesting for vaccine designs.</p><p>Several studies have reported the expansion of &#x003b3;&#x003b4; T cells in the blood and spleen of <italic>P. falciparum</italic>-exposed individuals (<xref rid="B50" ref-type="bibr">50</xref>&#x02013;<xref rid="B52" ref-type="bibr">52</xref>). In mice, &#x003b3;&#x003b4; T cells increased in frequency and absolute number in the spleen (<xref rid="B52" ref-type="bibr">52</xref>) and lungs after infection, with concomitant increase in absolute numbers of CD4+ and CD8+ T cells, suggesting that &#x003b3;&#x003b4; T cells could induce the recruitment of T cells after infection (<xref rid="B53" ref-type="bibr">53</xref>). A recent mouse study showed that expansion of the M-CSF-producing &#x003b3;&#x003b4; T cells subset after the acute phase of infection prevented the relapse of parasitemia (<xref rid="B54" ref-type="bibr">54</xref>). In CHMI, blood &#x003b3;&#x003b4; T cells also showed increased responsiveness to <italic>Plasmodium</italic> antigen <italic>in vitro</italic>; this response persisted for more than one year (<xref rid="B55" ref-type="bibr">55</xref>). Both studies showed the potential of peripheral blood &#x003b3;&#x003b4; T cells to prevent chronic <italic>Plasmodium</italic> infections and that <italic>Plasmodium</italic> antigens may induce memory-like &#x003b3;&#x003b4; T cells. Of note, memory-like &#x003b3;&#x003b4; T cell responses have been recently described for other infections (<xref rid="B56" ref-type="bibr">56</xref>&#x02013;<xref rid="B58" ref-type="bibr">58</xref>). Thus, understanding how these cells are activated may provide clues to new vaccination approaches.</p><p>The response of &#x003b3;&#x003b4; T-cell subsets appears to be multifactorial, depending on the age and ethnicity of the host and malaria endemicity. In studies performed in <italic>P. falciparum</italic> endemic areas, V&#x003b4;1+ T cells seem to be the dominant subset (<xref rid="B59" ref-type="bibr">59</xref>&#x02013;<xref rid="B61" ref-type="bibr">61</xref>), which do not corroborate the expansion and sustained response of peripheral blood V&#x003b3;9+V&#x003b4;2+ T cells observed in malaria-unexposed Caucasians (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>). Interestingly, the V&#x003b4;1+ subset also seems to predominate among healthy individuals in <italic>P. falciparum</italic> endemic areas (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B61" ref-type="bibr">61</xref>). Recent studies suggest that in malaria-endemic areas, the decreased or unresponsiveness of V&#x003b4;2+T cells may be associated with disease tolerance and, therefore, with the development of &#x02018;clinical immunity&#x02019; induced by successive malaria episodes (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>). Clarifying these mechanisms is essential to take advantage of &#x003b3;&#x003b4; T cells for therapeutic or preventive interventions.</p><p>In a study evaluating whole-organism <italic>P. falciparum</italic> Spz vaccine in Malian adults, the V&#x003b4;2+T cell subset expanded after vaccination and not V&#x003b4;1+ T cell subset (<xref rid="B34" ref-type="bibr">34</xref>). Understanding why we observed differences in &#x003b3;&#x003b4; T cell subset responders between endemic and non-endemic malaria populations and between children and adults from endemic regions requires further evaluation. Interestingly, RTS,S phase 3 trials in African children did not detect changes in total &#x003b3;&#x003b4; T cell frequencies after vaccination and detected negligible cytokine production by these cells upon <italic>in vitro</italic> circumsporozoite protein (CSP) stimulation (<xref rid="B66" ref-type="bibr">66</xref>). Future studies should characterize more specifically &#x003b3;&#x003b4; T cell subsets, such as V&#x003b4;2+ or V&#x003b4;1+ T cells, and not total &#x003b3;&#x003b4; T-cells, and evaluate whether these subsets correlate with protection.</p></sec><sec id="s6"><title>Concluding remarks</title><p>In summary, the use of strategies involving &#x003b3;&#x003b4; T cells in the context of malaria is a promising but challenging field of research because of the complexities of malaria infection. Moreover, most immunotherapy interventions are costly, especially those designed for cancer, and malaria is a widespread infectious disease in low- or middle-income countries. Nevertheless, several approaches should be pursued for the use of &#x003b3;&#x003b4; T cells in malaria (<xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1</bold>
</xref>).</p><fig position="float" id="f1"><label>Figure&#x000a0;1</label><caption><p>Potential use of human &#x003b3;&#x003b4; T cells-based immunotherapy for malaria. After a mosquito bite, &#x003b3;&#x003b4; T cells, especially V&#x003b4;1+, can engage with sporozoites (Spz) in the dermis, as well as recruited circulating V&#x003b4;2+ T cells. These cells can interact with other local immune cells and be activated by mosquito saliva components, malarial antigens, and stress-induced molecules. Skin-deliverable vaccines may enhance these interactions, promoting the subsequent development of adaptive immune responses, which, in turn, may increase Spz vaccination efficacy. Additionally, including &#x003b3;&#x003b4; T cell-activating molecules in skin-deliverable anti-malaria vaccines may increase their effectiveness. After leaving the skin, sporozoites quickly reach the liver, where V&#x003b4;1+ and V&#x003b4;3+ are the primary subsets of &#x003b3;&#x003b4; T cells. Studies on Spz immunization have suggested that liver-resident &#x003b3;&#x003b4; T cells contribute to the development of protective immunity against the parasite. This finding emphasizes the promise of these cells in increasing the effectiveness of malaria vaccines. Furthermore, circulating V&#x003b4;2+ T cells may migrate to the liver post-immunization. During the blood stage, the most mature forms of the parasite may interact with circulating and splenic V&#x003b4;2+ and V&#x003b4;1+ T cells and may be implicated in the control of parasitemia. Activating &#x003b3;&#x003b4; T cells with specific ligands may improve the anti-parasitic effects of conventional therapies, acting as an adjuvant therapy, and ultimately induce a memory-like &#x003b3;&#x003b4; T cell response. However, the specific &#x003b3;&#x003b4; T cell subset, ligands, and effector functions responsible for the potential protective role of &#x003b3;&#x003b4; T cells in malaria remain unclear. (?) means "unclear evidence in human malaria". Created with <uri xlink:href="https://BioRender.com">BioRender.com</uri>.</p></caption><graphic xlink:href="fimmu-14-1242306-g001" position="float"/></fig><p>One approach may involve the use of ligands for the activation of &#x003b3;&#x003b4; T cells to induce an antiparasitic effect in infected individuals (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B47" ref-type="bibr">47</xref>), which may be combined with conventional anti-malaria therapies. Identifying specific ligands that can selectively activate &#x003b3;&#x003b4; T subsets associated with parasite elimination or protection against severe manifestations of the disease and that have already been used in the contexts of other infections (<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B68" ref-type="bibr">68</xref>) and cancer (<xref rid="B69" ref-type="bibr">69</xref>&#x02013;<xref rid="B71" ref-type="bibr">71</xref>) is a challenging task. &#x003b3;&#x003b4; T cells can also be targeted in vaccine strategies. This can be achieved by incorporating specific &#x003b3;&#x003b4; T cell ligands into vaccines to induce a stronger adaptive immune response. &#x003b3;&#x003b4; T cells can act as antigen-presenting cells, contributing to the activation of the adaptive immune response and thus increasing the host&#x02019;s effectiveness against malaria (<xref rid="B48" ref-type="bibr">48</xref>). The activation of &#x003b3;&#x003b4; T cells can also be potentiated using specific adjuvants that stimulate innate immune cells, which in turn can promote the recruitment, proliferation, or memory-like phenotype on &#x003b3;&#x003b4; T cells (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B56" ref-type="bibr">56</xref>&#x02013;<xref rid="B58" ref-type="bibr">58</xref>). This can be combined with vaccine strategies to enhance the effectiveness of the immune response to the malaria parasite.</p><p>The fact that &#x003b3;&#x003b4; T cells populate several tissues and thus may interact with the various forms of Plasmodium parasites during each specific stage of the parasite life cycle dramatically increases the possibility of intervention using these cells. However, progress depends on the full understanding of the interactions between the parasite, host cells, &#x003b3;&#x003b4; T cells, and other immune cells, as well as the clarification of which &#x003b3;&#x003b4; T cell subsets correlate with immune protection and which ligands are most effective in activating these subsets.</p></sec><sec sec-type="author-contributions" id="s7"><title>Author contributions</title><p>AMV and AP conceived and wrote the manuscript. All authors contributed to the article and approved the submitted version.</p></sec></body><back><sec sec-type="COI-statement" id="s9"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s10"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>WHO</collab></person-group>. <source>World Malaria Report 2021</source>. (<year>2022</year>). (<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>).</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tavares</surname><given-names>J</given-names></name><name><surname>Formaglio</surname><given-names>P</given-names></name><name><surname>Thiberge</surname><given-names>S</given-names></name><name><surname>Mordelet</surname><given-names>E</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><name><surname>Medvinsky</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Role of host cell traversal by the malaria sporozoite during liver infection</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>:<page-range>905&#x02013;15</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20121130</pub-id>
</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sturm</surname><given-names>A</given-names></name><name><surname>Amino</surname><given-names>R</given-names></name><name><surname>van de Sand</surname><given-names>C</given-names></name><name><surname>Regen</surname><given-names>T</given-names></name><name><surname>Retzlaff</surname><given-names>S</given-names></name><name><surname>Rennenberg</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids</article-title>. <source>Science</source> (<year>2006</year>) <volume>313</volume>:<page-range>1287&#x02013;90</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1129720</pub-id>
</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dantzler</surname><given-names>KW</given-names></name><name><surname>de la Parte</surname><given-names>L</given-names></name><name><surname>Jagannathan</surname><given-names>P</given-names></name></person-group>. <article-title>Emerging role of gammadelta T cells in vaccine-mediated protection from infectious diseases</article-title>. <source>Clin Transl Immunol</source> (<year>2019</year>) <volume>8</volume>:<elocation-id>e1072</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/cti2.1072</pub-id>
</mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mensurado</surname><given-names>S</given-names></name><name><surname>Blanco-Dominguez</surname><given-names>R</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name></person-group>. <article-title>The emerging roles of gammadelta T cells in cancer immunotherapy</article-title>. <source>Nat Rev Clin Oncol</source> (<year>2023</year>) <volume>20</volume>:<page-range>178&#x02013;91</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41571-022-00722-1</pub-id>
</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Liao</surname><given-names>A</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name></person-group>. <article-title>Comparing mouse and human tissue-resident &#x003b3;&#x003b4; T cells</article-title>. <source>Front Immunol</source> (<year>2022</year>) <volume>13</volume>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.891687</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stanisic</surname><given-names>DI</given-names></name><name><surname>McCall</surname><given-names>MBB</given-names></name></person-group>. <article-title>Correlates of malaria vaccine efficacy</article-title>. <source>Expert Rev Vaccines</source> (<year>2021</year>) <volume>20</volume>:<page-range>143&#x02013;61</page-range>. doi: <pub-id pub-id-type="doi">10.1080/14760584.2021.1882309</pub-id>
</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sinnis</surname><given-names>P</given-names></name><name><surname>Zavala</surname><given-names>F</given-names></name></person-group>. <article-title>The skin: where malaria infection and the host immune response begin</article-title>. <source>Semin Immunopathol</source> (<year>2012</year>) <volume>34</volume>:<page-range>787&#x02013;92</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00281-012-0345-5</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amino</surname><given-names>R</given-names></name><name><surname>Thiberge</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Celli</surname><given-names>S</given-names></name><name><surname>Shorte</surname><given-names>S</given-names></name><name><surname>Frischknecht</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Quantitative imaging of Plasmodium transmission from mosquito to mammal</article-title>. <source>Nat Med</source> (<year>2006</year>) <volume>12</volume>:<page-range>220&#x02013;4</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nm1350</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hopp</surname><given-names>CS</given-names></name><name><surname>Sinnis</surname><given-names>P</given-names></name></person-group>. <article-title>The innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin</article-title>. <source>Ann N Y Acad Sci</source> (<year>2015</year>) <volume>1342</volume>:<fpage>37</fpage>&#x02013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1111/nyas.12661</pub-id>
<pub-id pub-id-type="pmid">25694058</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Hirai</surname><given-names>M</given-names></name><name><surname>Ishii</surname><given-names>A</given-names></name></person-group>. <article-title>A rodent malaria, Plasmodium berghei, is experimentally transmitted to mice by merely probing of infective mosquito, Anopheles stephensi</article-title>. <source>Parasitol Int</source> (<year>2002</year>) <volume>51</volume>:<fpage>17</fpage>&#x02013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1383-5769(01)00095-2</pub-id>
<pub-id pub-id-type="pmid">11880224</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roestenberg</surname><given-names>M</given-names></name><name><surname>McCall</surname><given-names>M</given-names></name><name><surname>Hopman</surname><given-names>J</given-names></name><name><surname>Wiersma</surname><given-names>J</given-names></name><name><surname>Luty</surname><given-names>AJ</given-names></name><name><surname>van Gemert</surname><given-names>GJ</given-names></name><etal/></person-group>. <article-title>Protection against a malaria challenge by sporozoite inoculation</article-title>. <source>N Engl J Med</source> (<year>2009</year>) <volume>361</volume>:<page-range>468&#x02013;77</page-range>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa0805832</pub-id>
</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bijker</surname><given-names>EM</given-names></name><name><surname>Teirlinck</surname><given-names>AC</given-names></name><name><surname>Schats</surname><given-names>R</given-names></name><name><surname>van Gemert</surname><given-names>GJ</given-names></name><name><surname>van de Vegte-Bolmer</surname><given-names>M</given-names></name><name><surname>van Lieshout</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites</article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>210</volume>:<page-range>1605&#x02013;15</page-range>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jiu293</pub-id>
</mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chakravarty</surname><given-names>S</given-names></name><name><surname>Cockburn</surname><given-names>IA</given-names></name><name><surname>Kuk</surname><given-names>S</given-names></name><name><surname>Overstreet</surname><given-names>MG</given-names></name><name><surname>Sacci</surname><given-names>JB</given-names></name><name><surname>Zavala</surname><given-names>F</given-names></name></person-group>. <article-title>CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes</article-title>. <source>Nat Med</source> (<year>2007</year>) <volume>13</volume>:<page-range>1035&#x02013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nm1628</pub-id>
</mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mantri</surname><given-names>CK</given-names></name><name><surname>St John</surname><given-names>AL</given-names></name></person-group>. <article-title>Immune synapses between mast cells and gammadelta T cells limit viral infection</article-title>. <source>J Clin Invest</source> (<year>2019</year>) <volume>129</volume>:<page-range>1094&#x02013;108</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI122530</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sumaria</surname><given-names>N</given-names></name><name><surname>Roediger</surname><given-names>B</given-names></name><name><surname>Ng</surname><given-names>LG</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Pinto</surname><given-names>R</given-names></name><name><surname>Cavanagh</surname><given-names>LL</given-names></name><etal/></person-group>. <article-title>Cutaneous immunosurveillance by self-renewing dermal gammadelta T cells</article-title>. <source>J Exp Med</source> (<year>2011</year>) <volume>208</volume>:<page-range>505&#x02013;18</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20101824</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quintana</surname><given-names>JF</given-names></name><name><surname>Sinton</surname><given-names>MC</given-names></name><name><surname>Chandrasegaran</surname><given-names>P</given-names></name><name><surname>Lestari</surname><given-names>AN</given-names></name><name><surname>Heslop</surname><given-names>R</given-names></name><name><surname>Cheaib</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>gammadelta T cells control murine skin inflammation and subcutaneous adipose wasting during chronic Trypanosoma brucei infection</article-title>. <source>Nat Commun</source> (<year>2023</year>) <volume>14</volume>:<fpage>5279</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-023-40962-y</pub-id>
<pub-id pub-id-type="pmid">37644007</pub-id>
</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JM</given-names></name><name><surname>Girardi</surname><given-names>M</given-names></name><name><surname>Roberts</surname><given-names>SJ</given-names></name><name><surname>Barbee</surname><given-names>SD</given-names></name><name><surname>Hayday</surname><given-names>AC</given-names></name><name><surname>Tigelaar</surname><given-names>RE</given-names></name></person-group>. <article-title>Selection of the cutaneous intraepithelial gammadelta+ T cell repertoire by a thymic stromal determinant</article-title>. <source>Nat Immunol</source> (<year>2006</year>) <volume>7</volume>:<page-range>843&#x02013;50</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni1363</pub-id>
</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>DR</given-names></name><name><surname>Hart</surname><given-names>R</given-names></name><name><surname>Bah</surname><given-names>N</given-names></name><name><surname>Ushakov</surname><given-names>DS</given-names></name><name><surname>Mu&#x000f1;oz-Ruiz</surname><given-names>M</given-names></name><name><surname>Feederle</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Normality sensing licenses local T cells for innate-like tissue surveillance</article-title>. <source>Nat Immunol</source> (<year>2022</year>) <volume>23</volume>:<page-range>411&#x02013;22</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-021-01124-8</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boyden</surname><given-names>LM</given-names></name><name><surname>Lewis</surname><given-names>JM</given-names></name><name><surname>Barbee</surname><given-names>SD</given-names></name><name><surname>Bas</surname><given-names>A</given-names></name><name><surname>Girardi</surname><given-names>M</given-names></name><name><surname>Hayday</surname><given-names>AC</given-names></name><etal/></person-group>. <article-title>Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T cells</article-title>. <source>Nat Genet</source> (<year>2008</year>) <volume>40</volume>:<page-range>656&#x02013;62</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ng.108</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>RA</given-names></name><name><surname>Altszuler</surname><given-names>R</given-names></name><name><surname>Frevert</surname><given-names>U</given-names></name><name><surname>Nardin</surname><given-names>EH</given-names></name></person-group>. <article-title>Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<fpage>32575</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep32575</pub-id>
<pub-id pub-id-type="pmid">27624667</pub-id>
</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daily</surname><given-names>JP</given-names></name></person-group>. <article-title>Shedding light on the role of the skin in vaccine-induced protection against the malaria sporozoite</article-title>. <source>mBio</source> (<year>2018</year>) <volume>9</volume>(<issue>6</issue>):<elocation-id>e02555-18</elocation-id>. doi: <pub-id pub-id-type="doi">10.1128/mBio.02555-18</pub-id>
<pub-id pub-id-type="pmid">30538191</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hung</surname><given-names>IF</given-names></name><name><surname>Zhang</surname><given-names>AJ</given-names></name><name><surname>To</surname><given-names>KK</given-names></name><name><surname>Chan</surname><given-names>JF</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial</article-title>. <source>Lancet Infect Dis</source> (<year>2016</year>) <volume>16</volume>:<page-range>209&#x02013;18</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(15)00354-0</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hung</surname><given-names>IF</given-names></name><name><surname>Zhang</surname><given-names>AJ</given-names></name><name><surname>To</surname><given-names>KK</given-names></name><name><surname>Chan</surname><given-names>JF</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>HS</given-names></name><etal/></person-group>. <article-title>Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial</article-title>. <source>Clin Infect Dis</source> (<year>2014</year>) <volume>59</volume>:<page-range>1246&#x02013;55</page-range>. doi: <pub-id pub-id-type="doi">10.1093/cid/ciu582</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Skountzou</surname><given-names>I</given-names></name><name><surname>Compans</surname><given-names>RW</given-names></name></person-group>. <article-title>Skin immunization with influenza vaccines</article-title>. <source>Curr Top Microbiol Immunol</source> (<year>2015</year>) <volume>386</volume>:<page-range>343&#x02013;69</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/82_2014_407</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hunter</surname><given-names>S</given-names></name><name><surname>Willcox</surname><given-names>CR</given-names></name><name><surname>Davey</surname><given-names>MS</given-names></name><name><surname>Kasatskaya</surname><given-names>SA</given-names></name><name><surname>Jeffery</surname><given-names>HC</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><etal/></person-group>. <article-title>Human liver infiltrating gammadelta T cells are composed of clonally expanded circulating and tissue-resident populations</article-title>. <source>J Hepatol</source> (<year>2018</year>) <volume>69</volume>:<page-range>654&#x02013;65</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jhep.2018.05.007</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mangan</surname><given-names>BA</given-names></name><name><surname>Dunne</surname><given-names>MR</given-names></name><name><surname>O'Reilly</surname><given-names>VP</given-names></name><name><surname>Dunne</surname><given-names>PJ</given-names></name><name><surname>Exley</surname><given-names>MA</given-names></name><name><surname>O'Shea</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vdelta3 T cells</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<page-range>30&#x02013;4</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1300121</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Groh</surname><given-names>V</given-names></name><name><surname>Steinle</surname><given-names>A</given-names></name><name><surname>Bauer</surname><given-names>S</given-names></name><name><surname>Spies</surname><given-names>T</given-names></name></person-group>. <article-title>Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells</article-title>. <source>Science</source> (<year>1998</year>) <volume>279</volume>:<page-range>1737&#x02013;40</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.279.5357.1737</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luoma</surname><given-names>AM</given-names></name><name><surname>Castro</surname><given-names>CD</given-names></name><name><surname>Mayassi</surname><given-names>T</given-names></name><name><surname>Bembinster</surname><given-names>LA</given-names></name><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Picard</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Crystal structure of Vdelta1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T cells</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>:<page-range>1032&#x02013;42</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2013.11.001</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name></person-group>. <article-title>Murine CXCR3(+)CXCR6(+)gammadeltaT cells reside in the liver and provide protection against HBV infection</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>757379</elocation-id>.<pub-id pub-id-type="pmid">35126348</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ribot</surname><given-names>JC</given-names></name><name><surname>Neres</surname><given-names>R</given-names></name><name><surname>Zuzarte-Lu&#x000ed;s</surname><given-names>V</given-names></name><name><surname>Gomes</surname><given-names>AQ</given-names></name><name><surname>Mancio-Silva</surname><given-names>L</given-names></name><name><surname>Mensurado</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>gammadelta-T cells promote IFN-gamma-dependent Plasmodium pathogenesis upon liver-stage infection</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>2019</year>) <volume>116</volume>:<page-range>9979&#x02013;88</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1073/pnas.1814440116</pub-id>
</mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chora</surname><given-names>AF</given-names></name><name><surname>Marques</surname><given-names>S</given-names></name><name><surname>Goncalves</surname><given-names>JL</given-names></name><name><surname>Lima</surname><given-names>P</given-names></name><name><surname>Gomes da Costa</surname><given-names>D</given-names></name><name><surname>Fernandez-Ruiz</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Interplay between liver and blood stages of Plasmodium infection dictates malaria severity via gammadelta T cells and IL-17-promoted stress erythropoiesis</article-title>. <source>Immunity</source> (<year>2023</year>) <volume>56</volume>:<fpage>592</fpage>&#x02013;<lpage>605.e598</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.immuni.2023.01.031</pub-id>
<pub-id pub-id-type="pmid">36804959</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seder</surname><given-names>RA</given-names></name><name><surname>Chang</surname><given-names>LJ</given-names></name><name><surname>Enama</surname><given-names>ME</given-names></name><name><surname>Zephir</surname><given-names>KL</given-names></name><name><surname>Sarwar</surname><given-names>UN</given-names></name><name><surname>Gordon</surname><given-names>IJ</given-names></name><etal/></person-group>. <article-title>Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine</article-title>. <source>Science</source> (<year>2013</year>) <volume>341</volume>:<page-range>1359&#x02013;65</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1241800</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaidi</surname><given-names>I</given-names></name><name><surname>Diallo</surname><given-names>H</given-names></name><name><surname>Conteh</surname><given-names>S</given-names></name><name><surname>Robbins</surname><given-names>Y</given-names></name><name><surname>Kolasny</surname><given-names>J</given-names></name><name><surname>Orr-Gonzalez</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>gammadelta T cells are required for the induction of sterile immunity during irradiated sporozoite vaccinations</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>199</volume>:<page-range>3781&#x02013;8</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1700314</pub-id>
</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsuji</surname><given-names>M</given-names></name><name><surname>Mombaerts</surname><given-names>P</given-names></name><name><surname>Lefrancois</surname><given-names>L</given-names></name><name><surname>Nussenzweig</surname><given-names>RS</given-names></name><name><surname>Zavala</surname><given-names>F</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group>. <article-title>Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1994</year>) <volume>91</volume>:<page-range>345&#x02013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.91.1.345</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McKenna</surname><given-names>KC</given-names></name><name><surname>Tsuji</surname><given-names>M</given-names></name><name><surname>Sarzotti</surname><given-names>M</given-names></name><name><surname>Sacci</surname><given-names>JB</given-names><suffix>Jr.</suffix></name><name><surname>Witney</surname><given-names>AA</given-names></name><name><surname>Azad</surname><given-names>AF</given-names></name></person-group>. <article-title>gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites</article-title>. <source>Infect Immun</source> (<year>2000</year>) <volume>68</volume>:<page-range>2224&#x02013;30</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.68.4.2224-2230.2000</pub-id>
</mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baptista</surname><given-names>FG</given-names></name><name><surname>Pamplona</surname><given-names>A</given-names></name><name><surname>Pena</surname><given-names>AC</given-names></name><name><surname>Mota</surname><given-names>MM</given-names></name><name><surname>Pied</surname><given-names>S</given-names></name><name><surname>Vigario</surname><given-names>AM</given-names></name></person-group>. <article-title>Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice</article-title>. <source>Infect Immun</source> (<year>2010</year>) <volume>78</volume>:<page-range>4033&#x02013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00079-10</pub-id>
</mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Claser</surname><given-names>C</given-names></name><name><surname>Malleret</surname><given-names>B</given-names></name><name><surname>Gun</surname><given-names>SY</given-names></name><name><surname>Wong</surname><given-names>AY</given-names></name><name><surname>Chang</surname><given-names>ZW</given-names></name><name><surname>Teo</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>CD8+ T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria</article-title>. <source>PLoS One</source> (<year>2011</year>) <volume>6</volume>:<elocation-id>e18720</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1371/journal.pone.0018720</pub-id>
<pub-id pub-id-type="pmid">21494565</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Milner</surname><given-names>DA</given-names><suffix>Jr.</suffix></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Frantzreb</surname><given-names>C</given-names></name><name><surname>Whitten</surname><given-names>RO</given-names></name><name><surname>Kamiza</surname><given-names>S</given-names></name><name><surname>Carr</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Quantitative assessment of multiorgan sequestration of parasites in fatal pediatric cerebral malaria</article-title>. <source>J Infect Dis</source> (<year>2015</year>) <volume>212</volume>:<page-range>1317&#x02013;21</page-range>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jiv205</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guenot</surname><given-names>M</given-names></name><name><surname>Loizon</surname><given-names>S</given-names></name><name><surname>Howard</surname><given-names>J</given-names></name><name><surname>Costa</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>DA</given-names></name><name><surname>Mohabeer</surname><given-names>SY</given-names></name><etal/></person-group>. <article-title>Phosphoantigen Burst upon Plasmodium falciparum Schizont Rupture Can Distantly Activate Vgamma9Vdelta2 T Cells</article-title>. <source>Infect Immun</source> (<year>2015</year>) <volume>83</volume>:<page-range>3816&#x02013;24</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00446-15</pub-id>
</mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parker</surname><given-names>CM</given-names></name><name><surname>Groh</surname><given-names>V</given-names></name><name><surname>Band</surname><given-names>H</given-names></name><name><surname>Porcelli</surname><given-names>SA</given-names></name><name><surname>Morita</surname><given-names>C</given-names></name><name><surname>Fabbi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire</article-title>. <source>J Exp Med</source> (<year>1990</year>) <volume>171</volume>:<page-range>1597&#x02013;612</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.171.5.1597</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davodeau</surname><given-names>F</given-names></name><name><surname>Peyrat</surname><given-names>MA</given-names></name><name><surname>Hallet</surname><given-names>MM</given-names></name><name><surname>Houde</surname><given-names>I</given-names></name><name><surname>Vie</surname><given-names>H</given-names></name><name><surname>Bonneville</surname><given-names>M</given-names></name></person-group>. <article-title>Peripheral selection of antigen receptor junctional features in a major human gamma delta subset</article-title>. <source>Eur J Immunol</source> (<year>1993</year>) <volume>23</volume>:<page-range>804&#x02013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.1830230405</pub-id>
</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Libero</surname><given-names>G</given-names></name><name><surname>Casorati</surname><given-names>G</given-names></name><name><surname>Giachino</surname><given-names>C</given-names></name><name><surname>Carbonara</surname><given-names>C</given-names></name><name><surname>Migone</surname><given-names>N</given-names></name><name><surname>Matzinger</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells</article-title>. <source>J Exp Med</source> (<year>1991</year>) <volume>173</volume>:<page-range>1311&#x02013;22</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.173.6.1311</pub-id>
</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Rosa</surname><given-names>SC</given-names></name><name><surname>Andrus</surname><given-names>JP</given-names></name><name><surname>Perfetto</surname><given-names>SP</given-names></name><name><surname>Mantovani</surname><given-names>JJ</given-names></name><name><surname>Herzenberg</surname><given-names>LA</given-names></name><name><surname>Herzenberg</surname><given-names>LA</given-names></name><etal/></person-group>. <article-title>Ontogeny of gamma delta T cells in humans</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>172</volume>:<page-range>1637&#x02013;45</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.172.3.1637</pub-id>
</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishizuka</surname><given-names>AS</given-names></name><name><surname>Lyke</surname><given-names>KE</given-names></name><name><surname>DeZure</surname><given-names>A</given-names></name><name><surname>Berry</surname><given-names>AA</given-names></name><name><surname>Richie</surname><given-names>TL</given-names></name><name><surname>Mendoza</surname><given-names>FH</given-names></name><etal/></person-group>. <article-title>Protection against malaria at 1 year and immune correlates following PfSPZ vaccination</article-title>. <source>Nat Med</source> (<year>2016</year>) <volume>22</volume>:<page-range>614&#x02013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nm.4110</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Papadopoulou</surname><given-names>M</given-names></name><name><surname>Taton</surname><given-names>M</given-names></name><name><surname>Genco</surname><given-names>F</given-names></name><name><surname>Marchant</surname><given-names>A</given-names></name><name><surname>Meroni</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Effector Vgamma9Vdelta2 T cell response to congenital Toxoplasma gondii infection</article-title>. <source>JCI Insight</source> (<year>2021</year>) <volume>6</volume>(<issue>16</issue>):<elocation-id>e138066</elocation-id>. doi: <pub-id pub-id-type="doi">10.1172/jci.insight.138066</pub-id>
<pub-id pub-id-type="pmid">34255746</pub-id>
</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Junqueira</surname><given-names>C</given-names></name><name><surname>Polidoro</surname><given-names>RB</given-names></name><name><surname>Castro</surname><given-names>G</given-names></name><name><surname>Absalon</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>Z</given-names></name><name><surname>Sen Santara</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>gammadelta T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis</article-title>. <source>Nat Immunol</source> (<year>2021</year>) <volume>22</volume>:<page-range>347&#x02013;57</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-020-00847-4</pub-id>
</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howard</surname><given-names>J</given-names></name><name><surname>Loizon</surname><given-names>S</given-names></name><name><surname>Tyler</surname><given-names>CJ</given-names></name><name><surname>Duluc</surname><given-names>D</given-names></name><name><surname>Moser</surname><given-names>B</given-names></name><name><surname>Mechain</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The antigen-presenting potential of vgamma9Vdelta2 T cells during plasmodium falciparum blood-stage infection</article-title>. <source>J Infect Dis</source> (<year>2017</year>) <volume>215</volume>:<page-range>1569&#x02013;79</page-range>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jix149</pub-id>
</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Frencher</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><etal/></person-group>. <article-title>Immunization of Vgamma2Vdelta2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2019</year>) <volume>116</volume>:<page-range>6371&#x02013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1811380116</pub-id>
</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goerlich</surname><given-names>R</given-names></name><name><surname>Hacker</surname><given-names>G</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><name><surname>Heeg</surname><given-names>K</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name></person-group>. <article-title>Plasmodium falciparum merozoites primarily stimulate the V gamma 9 subset of human gamma/delta T cells</article-title>. <source>Eur J Immunol</source> (<year>1991</year>) <volume>21</volume>:<page-range>2613&#x02013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.1830211045</pub-id>
</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goodier</surname><given-names>M</given-names></name><name><surname>Fey</surname><given-names>P</given-names></name><name><surname>Eichmann</surname><given-names>K</given-names></name><name><surname>Langhorne</surname><given-names>J</given-names></name></person-group>. <article-title>Human peripheral blood gamma delta T cells respond to antigens of Plasmodium falciparum</article-title>. <source>Int Immunol</source> (<year>1992</year>) <volume>4</volume>:<fpage>33</fpage>&#x02013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1093/intimm/4.1.33</pub-id>
<pub-id pub-id-type="pmid">1531764</pub-id>
</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakazawa</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>AE</given-names></name><name><surname>Maeno</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>CD</given-names></name><name><surname>Aikawa</surname><given-names>M</given-names></name></person-group>. <article-title>Malaria-induced increase of splenic gamma delta T cells in humans, monkeys, and mice</article-title>. <source>Exp Parasitol</source> (<year>1994</year>) <volume>79</volume>:<page-range>391&#x02013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1006/expr.1994.1101</pub-id>
</mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>A</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Characterization of gammadeltaT cells in lung of Plasmodium yoelii-infected C57BL/6 mice</article-title>. <source>Malar J</source> (<year>2021</year>) <volume>20</volume>:<fpage>89</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-021-03619-z</pub-id>
<pub-id pub-id-type="pmid">33588839</pub-id>
</mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mamedov</surname><given-names>MR</given-names></name><name><surname>Scholzen</surname><given-names>A</given-names></name><name><surname>Nair</surname><given-names>RV</given-names></name><name><surname>Cumnock</surname><given-names>K</given-names></name><name><surname>Kenkel</surname><given-names>JA</given-names></name><name><surname>Oliveira</surname><given-names>JHM</given-names></name><etal/></person-group>. <article-title>A macrophage colony-stimulating-factor-producing gammadelta T cell subset prevents malarial parasitemic recurrence</article-title>. <source>Immunity</source> (<year>2018</year>) <volume>48</volume>:<fpage>350</fpage>&#x02013;<lpage>63.e357</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.immuni.2018.01.009</pub-id>
<pub-id pub-id-type="pmid">29426701</pub-id>
</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teirlinck</surname><given-names>AC</given-names></name><name><surname>McCall</surname><given-names>MBB</given-names></name><name><surname>Roestenberg</surname><given-names>M</given-names></name><name><surname>Scholzen</surname><given-names>A</given-names></name><name><surname>Woestenenk</surname><given-names>R</given-names></name><name><surname>de Mast</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans</article-title>. <source>PLoS Pathog</source> (<year>2011</year>) <volume>7</volume>:<elocation-id>e1002389</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1002389</pub-id>
<pub-id pub-id-type="pmid">22144890</pub-id>
</mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoft</surname><given-names>DF</given-names></name><name><surname>Brown</surname><given-names>RM</given-names></name><name><surname>Roodman</surname><given-names>ST</given-names></name></person-group>. <article-title>Bacille Calmette-Guerin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>161</volume>:<page-range>1045&#x02013;54</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.161.2.1045</pub-id>
</mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gela</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Rodo</surname><given-names>M</given-names></name><name><surname>Hadley</surname><given-names>K</given-names></name><name><surname>Hanekom</surname><given-names>WA</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name><etal/></person-group>. <article-title>Effects of BCG vaccination on donor unrestricted T cells in two prospective cohort studies</article-title>. <source>EBioMedicine</source> (<year>2022</year>) <volume>76</volume>:<fpage>103839</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ebiom.2022.103839</pub-id>
<pub-id pub-id-type="pmid">35149285</pub-id>
</mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Qiu</surname><given-names>L</given-names></name><name><surname>Lai</surname><given-names>X</given-names></name><name><surname>Simon</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections</article-title>. <source>Science</source> (<year>2002</year>) <volume>295</volume>:<page-range>2255&#x02013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1068819</pub-id>
</mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hviid</surname><given-names>L</given-names></name><name><surname>Kurtzhals</surname><given-names>JA</given-names></name><name><surname>Adabayeri</surname><given-names>V</given-names></name><name><surname>Loizon</surname><given-names>S</given-names></name><name><surname>Kemp</surname><given-names>K</given-names></name><name><surname>Goka</surname><given-names>BQ</given-names></name><etal/></person-group>. <article-title>Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria</article-title>. <source>Infect Immun</source> (<year>2001</year>) <volume>69</volume>:<page-range>3190&#x02013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1128/IAI.69.5.3190-3196.2001</pub-id>
</mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Worku</surname><given-names>S</given-names></name><name><surname>Bjorkman</surname><given-names>A</given-names></name><name><surname>Troye-Blomberg</surname><given-names>M</given-names></name><name><surname>Jemaneh</surname><given-names>L</given-names></name><name><surname>Farnert</surname><given-names>A</given-names></name><name><surname>Christensson</surname><given-names>B</given-names></name></person-group>. <article-title>Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct gammadelta+ T cell patterns in Plasmodium falciparum and P. vivax infections</article-title>. <source>Clin Exp Immunol</source> (<year>1997</year>) <volume>108</volume>:<fpage>34</fpage>&#x02013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2249.1997.d01-981.x</pub-id>
<pub-id pub-id-type="pmid">9097908</pub-id>
</mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hviid</surname><given-names>L</given-names></name><name><surname>Akanmori</surname><given-names>BD</given-names></name><name><surname>Loizon</surname><given-names>S</given-names></name><name><surname>Kurtzhals</surname><given-names>JA</given-names></name><name><surname>Ricke</surname><given-names>CH</given-names></name><name><surname>Lim</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>High frequency of circulating gamma delta T cells with dominance of the v(delta)1 subset in a healthy population</article-title>. <source>Int Immunol</source> (<year>2000</year>) <volume>12</volume>:<fpage>797</fpage>&#x02013;<lpage>805</lpage>. doi: <pub-id pub-id-type="doi">10.1093/intimm/12.6.797</pub-id>
<pub-id pub-id-type="pmid">10837407</pub-id>
</mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>WL</given-names></name><name><surname>van der Heyde</surname><given-names>H</given-names></name><name><surname>Maki</surname><given-names>DG</given-names></name><name><surname>Malkovsky</surname><given-names>M</given-names></name><name><surname>Weidanz</surname><given-names>WP</given-names></name></person-group>. <article-title>Subset heterogeneity among gamma delta T cells found in peripheral blood during Plasmodium falciparum malaria</article-title>. <source>Immunol Lett</source> (<year>1992</year>) <volume>32</volume>:<page-range>273&#x02013;4</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0165-2478(92)90061-R</pub-id>
</mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roussilhon</surname><given-names>C</given-names></name><name><surname>Agrapart</surname><given-names>M</given-names></name><name><surname>Guglielmi</surname><given-names>P</given-names></name><name><surname>Bensussan</surname><given-names>A</given-names></name><name><surname>Brasseur</surname><given-names>P</given-names></name><name><surname>Ballet</surname><given-names>JJ</given-names></name></person-group>. <article-title>Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum</article-title>. <source>Clin Exp Immunol</source> (<year>1994</year>) <volume>95</volume>:<page-range>91&#x02013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2249.1994.tb06020.x</pub-id>
</mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jagannathan</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>CC</given-names></name><name><surname>Greenhouse</surname><given-names>B</given-names></name><name><surname>Nankya</surname><given-names>F</given-names></name><name><surname>Bowen</surname><given-names>K</given-names></name><name><surname>Eccles-James</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Loss and dysfunction of Vdelta2(+) gammadelta T cells are associated with clinical tolerance to malaria</article-title>. <source>Sci Transl Med</source> (<year>2014</year>) <volume>6</volume>(<issue>251</issue>):<elocation-id>251ra117</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.3009793</pub-id>
</mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jagannathan</surname><given-names>P</given-names></name><name><surname>Lutwama</surname><given-names>F</given-names></name><name><surname>Boyle</surname><given-names>MJ</given-names></name><name><surname>Nankya</surname><given-names>F</given-names></name><name><surname>Farrington</surname><given-names>LA</given-names></name><name><surname>McIntyre</surname><given-names>TI</given-names></name><etal/></person-group>. <article-title>Vdelta2+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>:<fpage>11487</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-017-10624-3</pub-id>
<pub-id pub-id-type="pmid">28904345</pub-id>
</mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moncunill</surname><given-names>G</given-names></name><name><surname>De Rosa</surname><given-names>SC</given-names></name><name><surname>Ayestaran</surname><given-names>A</given-names></name><name><surname>Nhabomba</surname><given-names>AJ</given-names></name><name><surname>Mpina</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>KW</given-names></name><etal/></person-group>. <article-title>RTS,S/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric African phase III trial</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>1008</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2017.01008</pub-id>
<pub-id pub-id-type="pmid">28878775</pub-id>
</mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tu</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Sia</surname><given-names>SF</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice</article-title>. <source>J Exp Med</source> (<year>2011</year>) <volume>208</volume>:<page-range>1511&#x02013;22</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20110226</pub-id>
</mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Sicard</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Phosphoantigen/IL2 expansion and differentiation of Vgamma2Vdelta2 T cells increase resistance to tuberculosis in nonhuman primates</article-title>. <source>PLoS Pathog</source> (<year>2013</year>) <volume>9</volume>:<elocation-id>e1003501</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1003501</pub-id>
<pub-id pub-id-type="pmid">23966854</pub-id>
</mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dieli</surname><given-names>F</given-names></name><name><surname>Vermijlen</surname><given-names>D</given-names></name><name><surname>Fulfaro</surname><given-names>F</given-names></name><name><surname>Caccamo</surname><given-names>N</given-names></name><name><surname>Meraviglia</surname><given-names>S</given-names></name><name><surname>Cicero</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Targeting human gammadelta T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer</article-title>. <source>Cancer Res</source> (<year>2007</year>) <volume>67</volume>:<page-range>7450&#x02013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-0199</pub-id>
</mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meraviglia</surname><given-names>S</given-names></name><name><surname>Eberl</surname><given-names>M</given-names></name><name><surname>Vermijlen</surname><given-names>D</given-names></name><name><surname>Todaro</surname><given-names>M</given-names></name><name><surname>Buccheri</surname><given-names>S</given-names></name><name><surname>Cicero</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>
<italic>In vivo</italic> manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients</article-title>. <source>Clin Exp Immunol</source> (<year>2010</year>) <volume>161</volume>:<page-range>290&#x02013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2249.2010.04167.x</pub-id>
</mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dong</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards Vdelta2(+) T cell cytotoxicity</article-title>. <source>Ann Hematol</source> (<year>2022</year>) <volume>101</volume>:<page-range>2195&#x02013;208</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00277-022-04930-8</pub-id>
</mixed-citation></ref></ref-list></back></article>
